Rui Yang

11.7k citations
115 papers · 2.8k indexed · 1 hit paper · h-index 31

Rui Yang

107 papers receiving 2.8k citations

Hit Papers

The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilit...3192020202620222024100200300

Peers

Rui Yang
Comparison fields: 5 of 121
  • Pharmaceutical Science 252
  • Cancer Research 535
  • Internal Medicine 103
  • Immunology 492
  • Hematology 254
Replace Sanjaya Singh with:
Sanjaya Singh United States
Jiong‐Wei Wang Singapore
Vladimir V. Shuvaev United States
Ronald J. Shebuski United States
Kamran Mansouri Iran
Manish Jain India
Jan A. A. M. Kamps Netherlands
Taher Nassar Israel
Mary Bebawy Australia
Saverio Candido Italy
Rui Yang relative to Sanjaya Singh United States Sanjaya Singh's profile →
Citations per field
00.5×5.4×
Sanjaya Singh · 1×
Citations per year

Countries citing papers authored by Rui Yang

Since Specialization
Citations

This map shows the geographic impact of Rui Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Yang more than expected).

Fields of papers citing papers by Rui Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Yang. The network helps show where Rui Yang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rui Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rui Yang Line = papers co-authored together Rui Yang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20251
3 20245
4 20248
5 20242
6 202313
7 20234
8 20235
9 20224
10 202015
11 202051
12 201971
13 201973
14 201928
15 201732
16 201615
17 20116
18
Five-minute purification of PCR products by new-freeze-squeeze method
20102
19 200818
20 200815

About Rui Yang

Rui Yang is a scholar working on Pharmaceutical Science, Immunology and Cancer Research, having authored 115 papers that have together received 2.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Cancer-related molecular mechanisms research (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Drug Solubulity and Delivery Systems (6 papers), Advanced Drug Delivery Systems (6 papers), MicroRNA in disease regulation (6 papers), Alcohol Consumption and Health Effects (6 papers) and Immune cells in cancer (6 papers). The work is most often cited by research in Pharmaceutical Science (252 citations), Cancer Research (535 citations) and Internal Medicine (103 citations). Rui Yang has collaborated with scholars based in China, United States and France. Frequent co-authors include Mercedes Rincón, Lei Xing, Rong Jiang, Luyu Zhang, Junxia Chen, Xiaosong Wang, Haibing He, Mengge Huang, Xing Tang and Tao Zeng. Their work appears in journals such as Bioorganic Chemistry, Drug Delivery, Scientific Reports, Frontiers in Immunology and Archives of Biochemistry and Biophysics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026